dc.description.abstract | Tuberculosis cases in Indonesia are ranked at the top
10 in the world, in which East Java Province is at the 2nd highest
tuberculosis cases from 33 provinces in Indonesia. In East Java,
the problem of severe tuberculosis occurs in such Tapal Kuda
regions as Jember, Bondowoso and Lumajang. The Case
Notification Rate in each of these areas is 137 / 100.000, 65 /
100.000 population and 74 / 100.000 population respectively. The
strategy to ensure patient recovery is the use of short-term antiTB
drug alloys and the application of drug control called the
Direct Observed Treatment Short Course (DOTS). In the
treatment of tuberculosis there is very possible the occurrence of
drop out treatment or drop out. Cases of drop out have a higher
risk of tuberculosis recurrence, anti-tuberculosis drug resistance,
and can transmit the infection to others. Based on the data from
the World Health Organization (WHO) in 2013, the resistance of
tuberculosis germs resulted from non-adherence treatment of
12.6%. The Drug Controller (PMO) plays an important role in
reminding, monitoring, and motivating TB patients to remain
obedient to treatment. This study aims to determine the
perspective of PMO in compliance to treatment of Madurese
ethnic tuberculosis patients in Tapal Kuda regions. The method
used is triangulation and verification using qualitative approach.
The results of the study showed that according to the PMO the
factors that influenced the treatment of Tuberculosis patients
during the treatment period were the lack of medical expenses,
the low of patient's confidence in the treatment, the lack of access
to health service, and the lack of motivation of the patient to
make good treatment and therefore there needs to be proactive
support from PMO and family as well as ongoing comprehensive
and proactive socialization related to the awareness raising of the
patient about the importance of tuberculosis treatment and the
improvement of patient understanding related to TB treatment. | en_US |